Back to today’s briefing

Story perspectives

Antiviral Drugs, Vaccines May Slash Alzheimer's Risk

7/15/2025

22 2

Summary

Story summary

Exciting new research reveals that antiviral drugs, particularly nucleoside reverse transcriptase inhibitors (NRTIs), could lower Alzheimer's risk by 6-13%. Furthermore, vaccines such as those for shingles and RSV may also play a role, with the RSV vaccine showing a promising 29% reduction in dementia risk. However, experts urge caution, emphasizing that more research is essential.

1 of 1

Story summary

Exciting new research reveals that antiviral drugs, particularly nucleoside reverse transcriptase inhibitors (NRTIs), could lower Alzheimer's risk by 6-13%. Furthermore, vaccines such as those for shingles and RSV may also play a role, with the RSV vaccine showing a promising 29% reduction in dementia risk. However, experts urge caution, emphasizing that more research is essential.